SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-251617
Filing Date
2009-12-11
Accepted
2009-12-11 17:15:25
Documents
3
Period of Report
2009-12-07
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 16947
2 PRESS RELEASE OF CORTEX PHARMACEUTICALS, INC. DATED DECEMBER 9, 2009 dex991.htm EX-99.1 7387
3 GRAPHIC g21086g32a57.jpg GRAPHIC 3021
  Complete submission text file 0001193125-09-251617.txt   30202
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16467 | Film No.: 091236973
SIC: 2834 Pharmaceutical Preparations